No Data
No Data
Guangyuyuan Chinese Herbal Medicine (600771.SH): Has not yet tried to transform towards new tracks.
On August 5th, Gelonhui reported that Guangyuyuan (600771.SH) is currently focusing on its main responsibilities and carrying out various tasks around its four core products in marketing breakthroughs. Regarding the innovative development of traditional Chinese medicine, based on mature and precise product formulation, processes, and efficacy, the company adheres to the fundamental principle of maintaining strict selection of materials and stable quality while conducting secondary product development without changing the guiding principles of advantages and high quality, and continuously launching high-quality traditional Chinese medicine products and related services while focusing on safety, effectiveness, and quality controllability. The company has not yet attempted a new transformation of its business model and also has not yet invested heavily nor developed in the direction of the new market.
Guangyuyuan Chinese Herbal Medicine (600771.SH): The company has no direct overseas business.
Guangyuyuan (600771.SH) stated on the investor interaction platform on August 5th that the company has no direct overseas business and the exchange rate fluctuations do not have a direct impact on the company's finances for the time being.
Guangyuyuan Chinese Herbal Medicine (600771.SH) has not cooperated with Huawei.
On July 25th, Gelonhui reported that Guangyuyuan chinese herbal medicine (600771.SH) stated on the investor communication platform that the company currently has no cooperation with Huawei. The construction of other brands is currently underway.
As GuangYuYuan Chinese Herbal Medicine (SHSE:600771) Ascends 4.8% This Past Week, Investors May Now Be Noticing the Company's Three-year Earnings Growth
Is GuangYuYuan Chinese Herbal Medicine (SHSE:600771) Using Too Much Debt?
Guangyuyuan Chinese Herbal Medicine (600771.SH): No product is included in the national centralized volume procurement pharmaceutical list.
Guangyuyuan Chinese Herbal Medicine (600771.SH) stated on the investor interaction platform on June 21st that the company currently has no products included in the national centralized drug procurement catalog or national negotiation drug catalog.
No Data